Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
International Journal of Cancer
|
October 16, 2013
The FOXE1 locus is a major genetic determinant for familial nonmedullary thyroid carcinoma
Elena Bonora, Cosmeri Rizzato, Chiara Diquigiovanni, et al.
Plos One
|
January 18, 2017
A Rasch Analysis of the Charcot-Marie-Tooth Neuropathy Score (CMTNS) in a Cohort of Charcot-Marie-Tooth Type 1A Patients
Wenjia Wang, Mickaël Guedj, Viviane Bertrand, et al.
Expert Opinion on Drug Discovery
|
July 5, 2022
Industrializing AI-powered drug discovery: lessons learned from the <i>Patrimony</i> computing platform
Mickaël Guedj, Jack Swindle, Antoine Hamon, et al.
Plos One
|
July 22, 2021
Network-based repurposing identifies anti-alarmins as drug candidates to control severe lung inflammation in COVID-19
Emiko Desvaux, Antoine Hamon, Sandra Hubert, et al.
Human Mutation
|
August 8, 2008
Variants of the MATP/SLC45A2 gene are protective for melanoma in the French population
Mickaël Guedj, Agnès Bourillon, Christophe Combadières, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 3, 2012
MC1R, SLC45A2 and TYR genetic variants involved in melanoma susceptibility in southern European populations: results from a meta-analysis
Maider Ibarrola-Villava, Hui-Han Hu, Mickaël Guedj, et al.
The Journal of Rheumatology
|
March 17, 2010
Phenotype-haplotype correlation of IRF5 in systemic sclerosis: role of 2 haplotypes in disease severity
Philippe Dieude, Karen Dawidowicz, Mickaël Guedj, et al.
Breast Cancer Research : BCR
|
August 18, 2010
Molecular apocrine differentiation is a common feature of breast cancer in patients with germline PTEN mutations
Guillaume Banneau, Mickaël Guedj, Gaëtan MacGrogan, et al.
Orphanet Journal of Rare Diseases
|
December 11, 2014
Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy
Ilya Chumakov, Aude Milet, Nathalie Cholet, et al.
Annals of the Rheumatic Diseases
|
October 29, 2010
The interferon regulatory factor 5 gene confers susceptibility to rheumatoid arthritis and influences its erosive phenotype
Karen Dawidowicz, Yannick Allanore, Mickaël Guedj, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
International Journal of Cancer
|
October 16, 2013
The FOXE1 locus is a major genetic determinant for familial nonmedullary thyroid carcinoma
Elena Bonora, Cosmeri Rizzato, Chiara Diquigiovanni, et al.
Plos One
|
January 18, 2017
A Rasch Analysis of the Charcot-Marie-Tooth Neuropathy Score (CMTNS) in a Cohort of Charcot-Marie-Tooth Type 1A Patients
Wenjia Wang, Mickaël Guedj, Viviane Bertrand, et al.
Expert Opinion on Drug Discovery
|
July 5, 2022
Industrializing AI-powered drug discovery: lessons learned from the <i>Patrimony</i> computing platform
Mickaël Guedj, Jack Swindle, Antoine Hamon, et al.
Plos One
|
July 22, 2021
Network-based repurposing identifies anti-alarmins as drug candidates to control severe lung inflammation in COVID-19
Emiko Desvaux, Antoine Hamon, Sandra Hubert, et al.
Human Mutation
|
August 8, 2008
Variants of the MATP/SLC45A2 gene are protective for melanoma in the French population
Mickaël Guedj, Agnès Bourillon, Christophe Combadières, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 3, 2012
MC1R, SLC45A2 and TYR genetic variants involved in melanoma susceptibility in southern European populations: results from a meta-analysis
Maider Ibarrola-Villava, Hui-Han Hu, Mickaël Guedj, et al.
The Journal of Rheumatology
|
March 17, 2010
Phenotype-haplotype correlation of IRF5 in systemic sclerosis: role of 2 haplotypes in disease severity
Philippe Dieude, Karen Dawidowicz, Mickaël Guedj, et al.
Breast Cancer Research : BCR
|
August 18, 2010
Molecular apocrine differentiation is a common feature of breast cancer in patients with germline PTEN mutations
Guillaume Banneau, Mickaël Guedj, Gaëtan MacGrogan, et al.
Orphanet Journal of Rare Diseases
|
December 11, 2014
Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy
Ilya Chumakov, Aude Milet, Nathalie Cholet, et al.
Annals of the Rheumatic Diseases
|
October 29, 2010
The interferon regulatory factor 5 gene confers susceptibility to rheumatoid arthritis and influences its erosive phenotype
Karen Dawidowicz, Yannick Allanore, Mickaël Guedj, et al.
Page
of 3